| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany; and
Basel Institute for Immunology, Basel, Switzerland
Local expression of IL-4 by gene-modified tumor cells increases their immunogenicity by inducing an inflammatory response that is dominated by eosinophils. Eosinophils have been implicated as antitumor effector cells because the application of a granulocyte-depleting Ab inhibited rejection of IL-4 transfected tumors. This Ab did not discriminate between eosinophils and neutrophils and, therefore, this experiment could not exclude neutrophils as primary effector cells, whereas eosinophils were innocent bystander cells in IL-4 transfected tumors. We analyzed tumor growth suppression and granulocyte infiltration in IL-5-deficient (IL-5-/-) mice that had a deficiency of eosinophils, using two tumor lines (B16-F10 and MCA205) transfected to secrete IL-4. IL-4-expressing tumors were at least as efficiently rejected in IL-5-/- mice as in wild-type mice, despite an almost complete absence of tumor-infiltrating eosinophils. However, neutrophils were present in undiminished amounts and their depletion partially restored tumor growth. Furthermore, the growth of IL-5-secreting tumors was not impaired in either wild-type or IL-5-/- mice, even though it induced eosinophilia in both mouse strains. These findings demonstrate that eosinophils can be induced in IL-5-/- mice by exogenous IL-5 and argue against a compensatory effect of neutrophils in the absence of eosinophils. We conclude that 1) infiltration of IL-4 transfected tumors by eosinophils is completely IL-5 dependent, 2) eosinophils have no tumoricidal activity, and 3) neutrophils are responsible, at least in part, for tumor suppression.
This article has been cited by other articles:
|
|
 |
|
  Z. Li, J. Jiang, Z. Wang, J. Zhang, M. Xiao, C. Wang, Y. Lu, and Z. Qin Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis Cancer Res., November 1, 2008; 68(21): 8687 - 8694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Shiratsuchi, T. Iyoda, N. Tanimoto, D. Kegai, K. Nagata, and Y. Kobayashi Infiltrating neutrophils induce allospecific CTL in response to immunization with apoptotic cells via MCP-1 production J. Leukoc. Biol., February 1, 2007; 81(2): 412 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Cormier, A. G. Taranova, C. Bedient, T. Nguyen, C. Protheroe, R. Pero, D. Dimina, S. I. Ochkur, K. O'Neill, D. Colbert, et al. Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host response J. Leukoc. Biol., June 1, 2006; 79(6): 1131 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Olver, P. Groves, K. Buttigieg, E. S. Morris, M. L. Janas, A. Kelso, and N. Kienzle Tumor-Derived Interleukin-4 Reduces Tumor Clearance and Deviates the Cytokine and Granzyme Profile of Tumor-Induced CD8+ T Cells Cancer Res., January 1, 2006; 66(1): 571 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Samoszuk, T. Deng, M. J. Hamamura, M.-Y. Su, N. Asbrock, and O. Nalcioglu Increased Blood Clotting, Microvascular Density, and Inflammation in Eotaxin-Secreting Tumors Implanted into Mice Am. J. Pathol., August 1, 2004; 165(2): 449 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Schuler, S. Kornig, and T. Blankenstein Tumor Rejection by Modulation of Tumor Stromal Fibroblasts J. Exp. Med., November 17, 2003; 198(10): 1487 - 1493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Chen, S.-H. Chen, J.-Y. Wang, and B.-C. Yang Fas Ligand on Tumor Cells Mediates Inactivation of Neutrophils J. Immunol., August 1, 2003; 171(3): 1183 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. van Spriel, H. H. van Ojik, A. Bakker, M. J. H. Jansen, and J. G. J. van de Winkel Mac-1 (CD11b/CD18) is crucial for effective Fc receptor-mediated immunity to melanoma Blood, January 1, 2003; 101(1): 253 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang, S. Wei, J. Sun, D. Coppola, B. Zhong, G. D. Wu, B. Goodwin, S. Sebti, J. Y. Djeu, and G. Blanck Retinoblastoma Protein Activation of Interleukin 8 Expression Inhibits Tumor Cell Survival in Nude Mice Cell Growth Differ., December 1, 2000; 11(12): 635 - 639. [Abstract] [Full Text]
|
|
|
|
|
|
D. Dombrowicz, B. Quatannens, J.-P. Papin, A. Capron, and M. Capron Expression of a Functional Fc{epsilon}RI on Rat Eosinophils and Macrophages J. Immunol., August 1, 2000; 165(3): 1266 - 1271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Dobrzanski, J. B. Reome, and R. W. Dutton Type 1 and Type 2 CD8+ Effector T Cell Subpopulations Promote Long-Term Tumor Immunity and Protection to Progressively Growing Tumor J. Immunol., January 15, 2000; 164(2): 916 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rodolfo, C. Zilocchi, P. Accornero, B. Cappetti, I. Arioli, and M. P. Colombo IL-4-Transduced Tumor Cell Vaccine Induces Immunoregulatory Type 2 CD8 T Lymphocytes That Cure Lung Metastases Upon Adoptive Transfer J. Immunol., August 15, 1999; 163(4): 1923 - 1928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Dobrzanski, J. B. Reome, and R. W. Dutton Therapeutic Effects of Tumor-Reactive Type 1 and Type 2 CD8+ T Cell Subpopulations in Established Pulmonary Metastases J. Immunol., June 1, 1999; 162(11): 6671 - 6680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Schuler, Z. Qin, S. Ibe, N. Noben-Trauth, and T. Blankenstein T Helper Cell Type 1-associated and Cytotoxic T Lymphocyte-mediated Tumor Immunity Is Impaired in Interleukin 4-deficient Mice J. Exp. Med., March 1, 1999; 189(5): 803 - 810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Benedetti, M. G. Bruzzone, B. Pollo, F. DiMeco, L. Magrassi, B. Pirola, N. Cirenei, M. P. Colombo, and G. Finocchiaro Eradication of Rat Malignant Gliomas by Retroviral-mediated, in Vivo Delivery of the Interleukin 4 Gene Cancer Res., February 1, 1999; 59(3): 645 - 652. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
